Share this postLeft’s NewsletterUPDATE: Moberg Pharma - Pharmacies report major demand for the new medicationCopy linkFacebookEmailNotesMoreUPDATE: Moberg Pharma - Pharmacies report major demand for the new medicationLeftFeb 07, 20249Share this postLeft’s NewsletterUPDATE: Moberg Pharma - Pharmacies report major demand for the new medicationCopy linkFacebookEmailNotesMoreShare"We have high expectations for the launch of MOB-015 - the first topical medication with an equivalent antifungal effect to tablets but without the risk of serious side effects. The goal is the same as last time, to achieve a market-leading position", says Mimmi Frölén, CEO of Allderma AB.
